Prism Medico & Pharmacy opened at ₹35.99, in line with its previous close of ₹35.99. In the last trading session on 12 Nov 2026, the stock traded between ₹35.10 and ₹37.47, with an average traded price of ₹36.06. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Prism Medico & Pharmacy is now worth
₹ 58,339.00
Giving a profit of
₹ 48,339.00 (483.39%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.18 (+0.50%)
Day High
₹37.47
Day Low
₹35.10
Day Open
₹35.99
Prev Close
₹35.99
Volume
2,881
Value Traded
₹0.01 Cr
1W Return
5.88%
1M Return
18.63%
3M Return
35.01%
6M Return
14.14%
1Y Return
81.30%
Market Cap (₹ Cr.)
49
PE Ratio
-599.80
PB Ratio
1.48
Dividend Yield
-
ROE
0.31%
ROCE
0.08%
Book Value (₹)
24.39
Face Value (₹)
10.00
EPS (TTM)
-0.07
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
5.88%
6 Weeks
-
1 Month
18.63%
3 Months
35.01%
9 Months
98.95%
Prism Medico & Pharmacy Q2FY27 Results: Net profit turns positive at ₹22.65 lakh
Prism Medico & Pharmacy Ltd posted a net profit of ₹22.65 lakh in Q2FY27, reversing a quarterly loss. Revenue from operations was ₹18.48 lakh, while other income contributed ₹26.19 lakh to total earnings. Cash and cash equivalents rose sharply to ₹1,662.55 lakh due to share warrant issuance proceeds. Operating activities generated negative cash flow of ₹93.80 lakh for the half-year period.
7 days agoPrism Medico confirms website functional per SEBI norms
Website confirmed functional per SEBI Regulation 46. Undertaking filed with BSE and MSEI on October 29, 2026. Signed by Director Davender Singh on behalf of the company.
14 days agoPrism Medico AGM resolutions pass with 99.99% shareholder approval
All 8 resolutions at Prism Medico & Pharmacy's 24th AGM on September 19, 2026 passed with 99.99% votes in favour. Shareholders approved investment in M/s. Infuze Well Private Limited under Section 186 of the Companies Act, 2013, and related equity subscription as a material related party transaction. Davender Singh (DIN: 09447213) was re-appointed as Director; M/s. Garg Mendiratta and Associates re-appointed as statutory auditors. M/s. SDK & Associates appointed as Secretarial Auditors for a five-year term from FY27 to FY31. Scrutinizer's report submitted on September 22, 2026 by M/s. M.R. Chechi & Associates confirmed no invalid votes across all resolutions.
1mo agoPrism Medico sets AGM for Sept 19; seeks approval for ₹23 cr Infuze Well stake
Prism Medico AGM scheduled for September 19, 2026. Seeks approval for ₹23 crore investment in Infuze Well. Book closure from September 13 to September 19, 2026. E-voting opens on September 16, closes on September 18.
2mo agoPrism Medico & Pharmacy Q1 Results: Net Loss of ₹5.83 Lakh Reported
Prism Medico & Pharmacy Ltd posted a net loss of ₹5.83 lakh in Q1FY27, reversing a net profit of ₹65.73 lakh in Q1FY26. Revenue from operations was nil, while total income was ₹9.06 lakh from other sources. Expenses totaled ₹14.89 lakh. Paid-up capital rose to ₹1,356.34 lakh.
3mo agoPrism Medico & Pharmacy confirms website functional per Reg 46
Prism Medico & Pharmacy Limited confirmed to BSE and MSEI on July 30, 2026, that its website is functional and compliant with SEBI Regulation 46. Director Davender Singh signed the undertaking, providing the URL https://www.prismmedico.in for investor access to mandatory disclosures under the LODR Regulations, 2015.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,104.80 | -0.91% | ₹6,87,843.43 | 31.30 | +9.04% | |
| ₹1,861.70 | -1.35% | ₹2,98,255.76 | 13.80 | -8.54% | |
| ₹974.15 | -2.95% | ₹2,29,221.88 | 18.60 | +18.44% | |
| ₹1,832.50 | -1.58% | ₹1,56,552.42 | 25.60 | +6.62% | |
| ₹355.05 | -0.45% | ₹1,50,714.08 | 24.40 | +9.18% | |
| ₹228.16 | -1.31% | ₹1,50,657.28 | 92.50 | -26.28% | |
| ₹11,158.00 | -0.95% | ₹1,24,181.30 | 13.30 | -7.00% | |
| ₹2,853.00 | -2.72% | ₹1,14,538.96 | 9.50 | -14.19% | |
| ₹410.20 | -2.22% | ₹1,12,301.56 | 24.90 | +24.45% | |
| ₹336.50 | -0.74% | ₹1,11,048.42 | 3.30 | -10.34% | |
| ₹83.96 | -1.56% | ₹1,09,723.18 | 15.10 | -30.95% | |
| ₹303.00 | -0.53% | ₹79,786.69 | 5.30 | -16.36% |
An investment of ₹10,000 made 5 years ago in Prism Medico & Pharmacy is now worth
₹ 58,339.00
Giving a profit of
₹ 48,339.00 (483.39%)
Note: Past profits do not guarantee future returns.
